Botao Fa

Botao Fa

Auto-generated profile, based on publicly available information

Botao Fa

Institute of Molecular and Translational Medicine (IMTM), Department of Biochemistry and Molecular Biology (DBMB), Xi’an Jiaotong University Health Science Center, Xi’an, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2026 in Nature Communications
Verified
Journal Article
Open access
BFBotao Fa
Botao Fa
CHChao Huang
Chao Huang
YMYixin Ma
Yixin Ma
WZWei Zhao
Wei Zhao
YXYungang Xu
Yungang Xu
ZXZhengtao Xiao
Zhengtao Xiao
Advances in single-cell and spatial technologies have transformed the dissection of cell composition and tissue architecture in complex biological systems. However, identifying rare cells critical to disease pathogenesis and biological processes remains difficult, as their low abundance often masks them among dominant cell populations. We introduce RareQ, a fast and scalable framework for rare cell detection by evaluating cliquishness of each cell’s k -nearest neighborhood using single-cell omics data. Extensive benchmarking on diverse simulated and real datasets demonstrates that RareQ exceeds existing methods in accuracy, sensitivity, and efficiency. RareQ also excels at identifying both modality-specific and shared rare cells. Its versatility across various biological contexts enables the discovery of functionally distinct rare cells with unique molecular signatures in physiological and pathological context. RareQ’s application to spatial transcriptomics data reveals anatomically distinct and clinically relevant rare cell populations. Together, RareQ offers an efficient approach for rare cell discovery, enhancing insights into tissue organization and disease mechanisms.

11 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
CHChao Huang
Chao Huang
YLYuhan Li
Yuhan Li
BFBotao Fa
Botao Fa
JZJinglin Zhu
Jinglin Zhu
ZLZhenni Liu
Zhenni Liu
ZXZhengtao Xiao
Zhengtao Xiao
Functional perturbations of genes do not always cause expression changes, but can manifest through network rewiring or context-specific shifts in regulatory activity. However, inferring functional shifts in genes and linking them to the specific cell populations remains challenging, as most current scRNA-seq data analysis focuses either on differential gene expression or on cell abundance/state changes, but rarely associate gene perturbations with particular cell populations. Here we present scDNS, a framework that quantifies gene-specific functional perturbations by measuring information-theoretic divergence between condition-specific gene interaction network configurations. In simulated stress tests and multiple experimental datasets, scDNS prioritizes key regulators and perturbed cell populations, even when expression changes are minimal but network rewiring is pronounced. Applications to immunodeficiency mutations, stimulus responses, and viral infection reveal hidden regulatory programs and heterogeneous responder cell states. In pancreatic cancer, scDNS nominates TIMM44 as a mitochondrial sensitizer enhancing gemcitabine efficacy. Together, scDNS provides a powerful tool for inferring dynamic gene perturbations in single cells.

25 November 2025 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
QQQiuhao Qu
Qiuhao Qu
YMYixin Ma
Yixin Ma
CHChao Huang
Chao Huang
BFBotao Fa
Botao Fa
ZLZhenni Liu
Zhenni Liu
ZXZhengtao Xiao
Zhengtao Xiao
The epithelial-to-mesenchymal transition (EMT) is a pivotal cellular process integral to metastasis. Emerging evidence indicates that EMT progresses through a continuum of cellular states, yet the intricate regulatory mechanisms underpinning this transition are not fully elucidated. This study aims to reconstruct the EMT spectrum in lung adenocarcinoma (LUAD) by integrating single-cell RNA sequencing data with advanced cell trajectory inference techniques. We identified five distinct EMT states across 16,310 malignant epithelial cells derived from 10 LUAD patients, encompassing epithelial, mesenchymal, and hybrid epithelial/mesenchymal (E/M) phenotypes. Notably, the hybrid E/M states exhibited the highest metastatic potential and were correlated with a poorer prognosis for patients. By modeling the EMT regulatory network, we evaluated the influence of transcription factor (TF) activation on network stability during cellular state transitions. We identified critical TFs, including TCF7, FOXA1, FOXA2, and SMAD7, which collectively regulate pathways such as TGF-β through both intrinsic EMT-related signaling and the modulation of tumor-associated macrophages. Furthermore, we developed a risk stratification model based on EMT continuum signatures, providing a novel tool for prognostic assessment. Our findings contribute to a comprehensive understanding of EMT-driven tumor evolution and open new avenues for prognostic stratification and targeted therapies in LUAD.